Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans

Petrakis, I., Springer, S. A., Davis, C., Ralevski, E., Gu, L., Lew, R., Hermos, J., Nuite, M., Gordon, A. J., Kosten, T. R., Nunes, E. V., Rosenheck, R., Saxon, A. J., Swift, R., Goldberg, A., Ringer, R., & Ferguson, R. (2022). Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans. Addiction Science & Clinical Practice, 17(1). https://doi.org/10.1186/s13722-022-00286-6
Authors:
Ismene Petrakis
Sandra A. Springer
Cynthia Davis
Elizabeth Ralevski
Lucy Gu
Robert Lew
John Hermos
Melynn Nuite
Adam J. Gordon
Thomas R. Kosten
Edward V. Nunes
Robert Rosenheck
Andrew J. Saxon
Robert Swift
Alexa Goldberg
Robert Ringer
Ryan Ferguson
Affiliated Authors:
Edward V. Nunes
Author Keywords:
opioid use disorder
buprenorphine
comparative effectiveness trial
veterans
injectable
Publication Type:
Article
Unique ID:
10.1186/s13722-022-00286-6
PMID:
Publication Date:
Data Source:
Scopus

Record Created: